Steve O'Loughlin
Finanzdirektor/CFO bei ACTINIUM PHARMACEUTICALS, INC.
Vermögen: 7 760 $ am 30.04.2024
Aktive Positionen von Steve O'Loughlin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACTINIUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 15.05.2017 | - |
Finanzdirektor/CFO | 15.05.2017 | - | |
Investor Relations Kontakt | - | - | |
Corporate Officer/Principal | 13.10.2015 | 15.05.2017 | |
Unternehmenssekretär | 15.05.2017 | - |
Karriereverlauf von Steve O'Loughlin
Ehemalige bekannte Positionen von Steve O'Loughlin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 01.08.2012 | 01.06.2015 |
Ausbildung von Steve O'Loughlin
Ramapo College of New Jersey | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Börse
- Insiders
- Steve O'Loughlin
- Erfahrung